NCT01819454

Brief Summary

The aim of the project is to define the frequency with which EER is present in patient with chronic rhinosinusitis (CHR). The measurement will be carried out with a 24-hour monitoring of the pH using the Restech system. This modern device is equipped with a narrow antimony probe. The sensor is able to record not only liquid but also aerosol reflux episodes. The second aim is to determine the relation among EER, CHR and asthma bronchiale. We will compare the presence of reflux in three different patient groups (1. CHR without nasal polyposis, without asthma bronchiale or ASA syndrome, 2. CHR with nasal polyposis, without asthma bronchiale or ASA syndrome, 3. CHR with nasal polyposis and asthma bronchiale and/or ASA syndrome). We expect to find a significantly more frequent presence of EER in patients with CHR and asthma bronchiale or ASA syndrome. In case our hypothesis is confirmed, it will be especially these patients(with a difficult to manage nasal polyposis) benefiting from the antireflux therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 27, 2013

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

September 8, 2016

Status Verified

September 1, 2016

Enrollment Period

3.1 years

First QC Date

March 22, 2013

Last Update Submit

September 7, 2016

Conditions

Keywords

chronic rhinosinusitisextraesophageal refluxRestech systemantireflux therapy

Outcome Measures

Primary Outcomes (1)

  • The frequency of the extraesophageal reflux in patients with chronic rhinosisnusitis

    EER will be measured using RYAN score, number of episodes and time of pH below 5.5

    3 years

Study Arms (3)

pH monitoring sinusitis no polyps

EXPERIMENTAL

30 patients with chronic rhinosinusitis without nasal polyposis, without asthma bronchiale or ASA syndrome

Device: pH monitoring (Restech)

pH monitoring sinusitis with polyp

EXPERIMENTAL

30 patients with chronic rhinosinusitis with nasal polyposis, without asthma bronchiale or ASA syndrome

Device: pH monitoring (Restech)

pH monitoring sinusitis, polyps, asthma

EXPERIMENTAL

30 patients with chronic rhinosinusitis with nasal polyposis and with asthma bronchiale and/or ASA syndrome

Device: pH monitoring (Restech)

Interventions

see in "detail description of the study" part of the protocol

Also known as: oropharyngeal pH monitoring using Restech system
pH monitoring sinusitis no polypspH monitoring sinusitis with polyppH monitoring sinusitis, polyps, asthma

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • signing of the informed consent
  • patients with chronic rhinosinusitis

You may not qualify if:

  • non-tolerance of the pH catheter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 70800, Czechia

Location

Related Publications (5)

  • DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing factor in refractory chronic rhinosinusitis. Laryngoscope. 2005 Jun;115(6):946-57. doi: 10.1097/01.MLG.0000163751.00885.63.

    PMID: 15933499BACKGROUND
  • Katle EJ, Hatlebakk JG, Steinsvag S. Gastroesophageal reflux and rhinosinusitis. Curr Allergy Asthma Rep. 2013 Apr;13(2):218-23. doi: 10.1007/s11882-013-0340-5.

    PMID: 23371037BACKGROUND
  • Loehrl TA, Samuels TL, Poetker DM, Toohill RJ, Blumin JH, Johnston N. The role of extraesophageal reflux in medically and surgically refractory rhinosinusitis. Laryngoscope. 2012 Jul;122(7):1425-30. doi: 10.1002/lary.23283. Epub 2012 Apr 26.

    PMID: 22539181BACKGROUND
  • Hanna BC, Wormald PJ. Gastroesophageal reflux and chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2012 Feb;20(1):15-8. doi: 10.1097/MOO.0b013e32834e8f11.

    PMID: 22157165BACKGROUND
  • Zelenik K, Matousek P, Formanek M, Urban O, Kominek P. Patients with chronic rhinosinusitis and simultaneous bronchial asthma suffer from significant extraesophageal reflux. Int Forum Allergy Rhinol. 2015 Oct;5(10):944-9. doi: 10.1002/alr.21560. Epub 2015 Jun 5.

MeSH Terms

Conditions

Nose DiseasesNasal PolypsLaryngopharyngeal Reflux

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsGastroesophageal RefluxEsophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesLaryngeal Diseases

Study Officials

  • Karol Zelenik, MD,PhD

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2013

First Posted

March 27, 2013

Study Start

August 1, 2012

Primary Completion

September 1, 2015

Study Completion

December 1, 2015

Last Updated

September 8, 2016

Record last verified: 2016-09

Locations